Terbutaline

Chemical formula: C₁₂H₁₉NO₃  Molecular mass: 225.284 g/mol  PubChem compound: 5403

Therapeutic indications

Terbutaline is indicated for:

Bronchospasm

Population group: only adults (18 years old or older)

Terbutaline is a selective beta2-adrenergic agonist recommended for the relief of bronchospasm in bronchial asthma and other bronchopulmonary disorders in which bronchospasm or reversible airways obstruction is a complicating factor.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Short term management of uncomplicated premature labour

Population group: only adults (18 - 65 years old)

To arrest labour between 22 and 37 weeks of gestation in patients with no medical or obstetric contraindication to tocolytic therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Terbutaline is contraindicated in the following cases:

Hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy

Halogenated anaesthetics

Halogenated hydrocarbons

Gestational age of <22 weeks

at least one of
Gestation less than 20 weeks
Gestation period, 21 weeks

Threatened abortion during the 1st and 2nd trimester

at least one of
Threatened abortion in first trimester
Threatened abortion in second trimester

Conditions of the mother or foetus in which prolongation of the pregnancy is hazardous

at least one of
Pre-eclampsia
Infection of uterus
Placenta praevia with haemorrhage
Hemorrhagic complication of pregnancy

Intrauterine foetal death, known lethal congenital or lethal chromosomal malformation

at least one of
Fetal death
Congenital malformation
Chromosomal disorder

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2022: BRICANYL Tablet
Summary of Product Characteristics (SPC) 2023: BRICANYL TURBOHALER Inhalation powder
Summary of Product Characteristics (SPC) 2022: BRICANYL Solution for injection or infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈